Literature DB >> 18182451

Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.

Guolian Li1, Juan-Pablo Del Rincon, Linda A Jahn, Yangsong Wu, Bruce Gaylinn, Michael O Thorner, Zhenqi Liu.   

Abstract

CONTEXT: Endothelial dysfunction is common in patients with GH deficiency who are at increased risk for premature cardiovascular death. GH regulates vascular tone and reactivity in humans.
OBJECTIVE: Our objective was to explore the mechanisms underlying the GH's acute vascular effects. DESIGN AND STUDY
SETTING: There were 10 healthy, lean and young, volunteers studied after an overnight fast. GH was infused systemically for 6 h at 0.06 microg/kg.min. Biopsy of the vastus lateralis muscle was done in seven subjects before and after GH infusion. Human aortic endothelial cells (HAECs) were incubated with GH in vitro.
RESULTS: GH infusion increased plasma GH to 32.9 +/- 1.5 ng/ml and forearm blood flow by 66% (P < 0.001). GH infusion did not significantly change plasma IGF-I concentrations, muscle IGF-I mRNA expression, and muscle Akt phosphorylation, suggesting a lack of IGF-I action in muscle. Because it was reported that GH exerts an acute vascular effect via a nitric oxide (NO)-dependent mechanism, we performed additional in vitro experiments using HAECs. HAECs express abundant GH receptors. Incubating HAECs with GH at 30 ng/ml for 3 or 6 h did not alter endothelial NO synthase (eNOS) protein content but time dependently increased the phosphorylation and activity of eNOS, thus demonstrating a direct effect of GH on endothelial cells.
CONCLUSIONS: GH exerts an acute vascular effect independent of both systemic and local IGF-I production, and this effect is likely via direct action on GH receptors and eNOS in the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182451      PMCID: PMC2291494          DOI: 10.1210/jc.2007-2021

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

Review 1.  Growth hormone and the insulin-like growth factor system in myogenesis.

Authors:  J R Florini; D Z Ewton; S A Coolican
Journal:  Endocr Rev       Date:  1996-10       Impact factor: 19.871

2.  Topography of growth hormone receptor expression in the bovine embryo.

Authors:  S Kölle; F Sinowatz; G Boie; D Lincoln; G Palma; M Stojkovic; E Wolf
Journal:  Histochem Cell Biol       Date:  1998-04       Impact factor: 4.304

3.  Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

Authors:  G Zeng; M J Quon
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats.

Authors:  Anna Wickman; Ingibjorg H Jonsdottir; Goran Bergstrom; Lars Hedin
Journal:  Eur J Endocrinol       Date:  2002-10       Impact factor: 6.664

5.  Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

Authors:  R H Böger; C Skamira; S M Bode-Böger; G Brabant; A von zur Muhlen; J C Frolich
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes.

Authors:  M Ridderstråle; E Degerman; H Tornqvist
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

7.  IGF-I increases forearm blood flow without increasing forearm glucose uptake.

Authors:  M Pendergrass; E Fazioni; D Collins; R A DeFronzo
Journal:  Am J Physiol       Date:  1998-08

8.  Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism.

Authors:  D A Fryburg
Journal:  Am J Physiol       Date:  1994-08

9.  Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.

Authors:  L S Argetsinger; G W Hsu; M G Myers; N Billestrup; M F White; C Carter-Su
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.

Authors:  E Kilgour; I Gout; N G Anderson
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

View more
  12 in total

Review 1.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

Review 2.  Hormonal modulation of endothelial NO production.

Authors:  Sue P Duckles; Virginia M Miller
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

3.  The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.

Authors:  Carmen Gonzalez; Hector Rosas-Hernandez; Brenda Jurado-Manzano; Manuel Alejandro Ramirez-Lee; Samuel Salazar-Garcia; Pedro Pablo Martinez-Cuevas; Aída Jimena Velarde-Salcedo; Humberto Morales-Loredo; Ricardo Espinosa-Tanguma; Syed F Ali; Rafael Rubio
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

4.  Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly.

Authors:  Cigdem Ozkan; Alev Eroglu Altinova; Ethem Turgay Cerit; Cagri Yayla; Asife Sahinarslan; Duygu Sahin; Aylin Sepici Dincel; Fusun Balos Toruner; Mujde Akturk; Metin Arslan
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

5.  Functional Changes after Recombinant Human Growth Hormone Replacement in Patients with Chronic Traumatic Brain Injury and Abnormal Growth Hormone Secretion.

Authors:  Kurt A Mossberg; William J Durham; Dennis J Zgaljardic; Charles R Gilkison; Christopher P Danesi; Melinda Sheffield-Moore; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2016-10-13       Impact factor: 5.269

Review 6.  L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.

Authors:  Kevin S Heffernan; Christopher A Fahs; Sushant M Ranadive; Eshan A Patvardhan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-01-06       Impact factor: 2.457

Review 7.  Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.

Authors:  Diego Caicedo; Pablo Devesa; Víctor M Arce; Julia Requena; Jesús Devesa
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-12-22

8.  Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome.

Authors:  Jessica K Devin; Hui Nian; Jorge E Celedonio; Patricia Wright; Nancy J Brown
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

Review 9.  Growth Hormone (GH) and Cardiovascular System.

Authors:  Diego Caicedo; Oscar Díaz; Pablo Devesa; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2018-01-18       Impact factor: 5.923

10.  Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women.

Authors:  Jessica R Wilson; Nancy J Brown; Hui Nian; Chang Yu; Martin Bidlingmaier; Jessica K Devin
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.